Renal cancer-selective Englerin A induces multiple mechanisms of cell death and autophagy

por Williams, Richard T, Yu, Alice L, Diccianni, Mitchell B, Theodorakis, Emmanuel A, Batova, Ayse
Publicado 2013

Erratum: renal cancer-selective Englerin A induces multiple mechanisms of cell death and autophagy

por Williams, Richard T, Yu, Alice L, Diccianni, Mitchell B, Theodorakis, Emmanuel A, Batova, Ayse
Publicado 2014

Anti-GD2 induced allodynia in rats can be reduced by pretreatment with DFMO

por Diccianni, Mitchell B., Kempińska, Katarzyna, Gangoti, Jon A., Yu, Alice L., Sorkin, Linda S.
Publicado 2020

Chimeras of p14ARF and p16: Functional Hybrids with the Ability to Arrest Growth

por Williams, Richard T., Barnhill, Lisa M., Kuo, Huan-Hsien, Lin, Wen-Der, Batova, Ayse, Yu, Alice L., Diccianni, Mitchell B.
Publicado 2014

Chimeric Antibody c.8B6 to O-Acetyl-GD2 Mediates the Same Efficient Anti-Neuroblastoma Effects as Therapeutic ch14.18 Antibody to GD2 without Antibody Induced Allodynia

por Terme, Mickaël, Dorvillius, Mylène, Cochonneau, Denis, Chaumette, Tanguy, Xiao, Wenhua, Diccianni, Mitchell B., Barbet, Jacques, Yu, Alice L., Paris, François, Sorkin, Linda S., Birklé, Stéphane
Publicado 2014

Englerin A induces an acute inflammatory response and reveals lipid metabolism and ER stress as targetable vulnerabilities in renal cell carcinoma

por Batova, Ayse, Altomare, Diego, Creek, Kim E., Naviaux, Robert K., Wang, Lin, Li, Kefeng, Green, Erica, Williams, Richard, Naviaux, Jane C., Diccianni, Mitchell, Yu, Alice L.
Publicado 2017

MPDA: Microarray pooled DNA analyzer

por Yang, Hsin-Chou, Huang, Mei-Chu, Li, Ling-Hui, Lin, Chien-Hsing, Yu, Alice LT, Diccianni, Mitchell B, Wu, Jer-Yuarn, Chen, Yuan-Tsong, Fann, Cathy SJ
Publicado 2008

A Comprehensive Safety Trial of Chimeric Antibody 14.18 With GM-CSF, IL-2, and Isotretinoin in High-Risk Neuroblastoma Patients Following Myeloablative Therapy: Children’s Oncology...

por Ozkaynak, M. Fevzi, Gilman, Andrew L., London, Wendy B., Naranjo, Arlene, Diccianni, Mitchell B., Tenney, Sheena C., Smith, Malcolm, Messer, Karen S., Seeger, Robert, Reynolds, C. Patrick, Smith, L. Mary, Shulkin, Barry L., Parisi, Marguerite, Maris, John M., Park, Julie R., Sondel, Paul M., Yu, Alice L.
Publicado 2018

Corrigendum: A Comprehensive Safety Trial of Chimeric Antibody 14.18 With GM-CSF, IL-2, and Isotretinoin in High-Risk Neuroblastoma Patients Following Myeloablative Therapy: Childr...

por Ozkaynak, M. Fevzi, Gilman, Andrew L., London, Wendy B., Naranjo, Arlene, Diccianni, Mitchell B., Tenney, Sheena C., Smith, Malcolm, Messer, Karen S., Seeger, Robert, Reynolds, C. Patrick, Smith, L. Mary, Shulkin, Barry L., Parisi, Marguerite, Maris, John M., Park, Julie R., Sondel, Paul M., Yu, Alice L.
Publicado 2018